← Back to Search

Healthcare Professionals (HCPs) for Primary Immunodeficiency

N/A
Recruiting
Research Sponsored by Takeda
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

Study Summary

The main aim of this study is to determine the impact of digital health technology, such as Alexa Skill, used to support the initiation of home-based subcutaneous immunoglobulin (SCIG) treatment, treatment management, and overall participant experience.

Eligible Conditions
  • Primary Immunodeficiency

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Identify Participant Experience, Including Convenience and Satisfaction, With Alexa Skill

Trial Design

3Treatment groups
Experimental Treatment
Group I: Healthcare Professionals (HCPs)Experimental Treatment1 Intervention
HCPs, specifically, clinical immunologists who prescribe SCIG for the treatment of PID and nurses who have experience administering SCIG will be interviewed after the use of Alexa Skill.
Group II: Caregivers of Patients with a Self-reported Diagnosis of PIDExperimental Treatment1 Intervention
Caregivers who recently started or will soon begin infusing SCIG (HyQvia or Cuvitru) for patients with a self-reported diagnosis of PID will be interviewed before and/or after the use of Alexa Skill.
Group III: Adult Patients with PIDExperimental Treatment1 Intervention
Adult patients with PID who recently started or will soon begin to complete SCIG (HyQvia or Cuvitru) infusions independently will be interviewed before and/or after the use of Alexa Skill.

Find a Location

Who is running the clinical trial?

TakedaLead Sponsor
1,202 Previous Clinical Trials
4,178,226 Total Patients Enrolled
Study DirectorStudy DirectorTakeda
1,207 Previous Clinical Trials
489,644 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa Skill
2023. "At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa Skill". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06150534.
All > High Point > Greensboro
~0 spots leftby Apr 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top